-
Loading metrics
Open Access
Peer-reviewed
Research Article
Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication
-
Krystelle Nganou-Makamdop,
Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing
Current address: Institute of Clinical and Molecular Virology, University Hospital Erlangen, Erlangen, Germany.
Affiliation Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
James M. Billingsley,
Roles Formal analysis, Software, Writing – original draft, Writing – review & editing
Affiliation Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America
⨯ -
Zachary Yaffe,
Roles Formal analysis, Investigation, Methodology
Affiliation Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Gregory O’Connor,
Roles Formal analysis, Investigation, Methodology
Affiliation Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Gregory K. Tharp,
Roles Formal analysis, Resources, Software
Affiliation Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America
⨯ -
Amy Ransier,
Roles Methodology
Affiliation Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Farida Laboune,
Roles Methodology
Affiliation Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Rodrigo Matus-Nicodemos,
Roles Methodology
Affiliation Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Andrea Lerner,
Roles Methodology
Affiliation Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Lavina Gharu,
Roles Methodology
Affiliation Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Jennifer M. Robertson,
Roles Formal analysis, Methodology
Affiliation Department of Surgery and Emory Transplant Center, Emory University School of Medicine and Emory Healthcare, Atlanta, GA
⨯ -
Mandy L. Ford,
Roles Formal analysis, Methodology
Affiliation Department of Surgery and Emory Transplant Center, Emory University School of Medicine and Emory Healthcare, Atlanta, GA
⨯ -
Martin Schlapschy,
Roles Formal analysis, Methodology, Writing – review & editing
Affiliation Lehrstuhl für Biologische Chemie, Technische Universität München, Freising (Weihenstephan), Germany
⨯ -
Nadine Kuhn,
Roles Methodology
Affiliation Lehrstuhl für Biologische Chemie, Technische Universität München, Freising (Weihenstephan), Germany
⨯ -
Alexandra Lensch,
Roles Methodology
Affiliation Lehrstuhl für Biologische Chemie, Technische Universität München, Freising (Weihenstephan), Germany
⨯ -
Jeffrey Lifson,
Roles Formal analysis, Funding acquisition, Investigation, Methodology
Affiliation AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
Martha Nason,
Roles Formal analysis, Methodology
Affiliation Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Arne Skerra,
Roles Formal analysis, Investigation, Methodology, Resources, Supervision, Writing – review & editing
Affiliations Lehrstuhl für Biologische Chemie, Technische Universität München, Freising (Weihenstephan), Germany, XL-protein GmbH, Freising, Germany
⨯ -
Gideon Schreiber,
Roles Conceptualization, Investigation, Resources, Supervision, Writing – review & editing
Affiliation Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
⨯ -
Steven E. Bosinger,
Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Supervision, Visualization, Writing – original draft, Writing – review & editing
Affiliations Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, Georgia, United States of America, Department of Pathology & Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America
⨯ - [ ... ],
-
Daniel C. Douek
Roles Conceptualization, Data curation, Funding acquisition, Investigation, Supervision, Visualization, Writing – original draft, Writing – review & editing
* E-mail: ddouek@mail.nih.gov
Affiliation Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ - [ view all ]
- [ view less ]
Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication
- Krystelle Nganou-Makamdop,
- James M. Billingsley,
- Zachary Yaffe,
- Gregory O’Connor,
- Gregory K. Tharp,
- Amy Ransier,
- Farida Laboune,
- Rodrigo Matus-Nicodemos,
- Andrea Lerner,
- Lavina Gharu
-
- Published: August 24, 2018
- https://doi.org/10.1371/journal.ppat.1007246